BSECompany Update4 Aug 2026 · 4 Aug 2026, 06:28 pm

We hereby submit the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Appointment of Investor and Public Relations agency of the Company.

Speciality Medicines Ltd · 544738

✦ AI Summary

Speciality Medicines Ltd has appointed Capital Bridge Advisory Service Private Limited as its Investor and Public Relations Agency, enhancing its investor relations and capital market communication efforts.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Speciality Medicines Ltd - 544738 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Appointment Of Investor And Public Relations Agency Of The Company

Attachments (1)

📄

a21e10c4-7f42-4915-ab96-fdc0b65f0150.pdf

pdf

Download →
View document text
Exporter & Trader of Speciality Medicines Date: - August 04, 2026 BSE Limited. PJ Towers, Dalal Street, Mumbai – 400001 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Appointment of Investor and Public Relations Agency of the Company Reference: Speciality Medicines Limited (Id: SPML; Code: 544738) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the company has appointed “Capital Bridge Advisory Service Private Limited” (operating under the brand name Capital Bridge Advisors), having its registered office at 301, Vastubh Apartments, Dattapada Cross Road No 1, Near Hanuman Temple, Borivali East, Mumbai - 400066, as our “Investor and Public Relations Agency" for providing Investor and Public Relations Advisory Services. Capital Bridge Advisory Service Private Limited will assist the company in enhancing its investor relations and capital market communication efforts, with a focus on fostering meaningful engagement with the investment community. This engagement reflects the company's continued commitment to strengthening its investor relations framework, promoting greater transparency, and ensuring effective communication with stakeholders in line with the evolving expectations of institutional and retail investors. Details of the Investor and Public Relations Agency is as follows: Research Team Email: info@capbridge.in Contact No.: +079 4918 4116 Corporate Office Address: 812 - 8th Floor, Tower B, Shilp Corporate Park, Rajpath Rangoli Road – 380058 This is for your information and records. Yours Faithfully, For, SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) Parthkumar Goyani Chairman and Managing Director DIN: 07885789 Place: Mumbai SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) CIN: L85300GJ2021PLC120022 Corp. Office : Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, 20 Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra, India, 400093 Regd. Office : 913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmedabad 380051, Gujarat, India +91 99242 03751 / 99242 43751 info@specialitymedicine.com www.specialitymedicine.com